Technology Available for Industry-Academia Collaboration or Technology Licensing. “Characterizing molecular and clinical features in hepatopancreatobiliary cancers”
Technology Available for Industry-Academia Collaboration or Technology Licensing. “Characterizing molecular and clinical features in hepatopancreatobiliary cancers” Date: 2026.07.13 Title: NHRI technology, “Characterizing molecular and clinical features in hepatopancreatobiliary cancers” available for industry-academia collaboration or technology licensing. Description: Previous studies have indicated that hepatopancreatobiliary cancers patients with different mutations tend to have different overall survival (OS), …
